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Liver plays a key role in metabolism and detoxiﬁcation, therefore analysis of its proteome
is  relevant for toxicology and drug discovery studies. To optimize for high proteome cov-
erage, protein and peptide-level ion exchange fractionation were assessed using rat liver
microsomes and S9 fractions. 2D-(SCX-RP)-LC–MS/MS analysis with peptide fractionation
was  subsequently employed for rat, mouse and human samples, yielding between 1400 and
1939 identiﬁed proteins, 58% of which were shared between species, and with relatively high
sequence coverage. This rich dataset is speciﬁcally interesting for the toxicology community,
and could serve as an excellent source for targeted assay development.
©  2015 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).spectrometry
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Cross-species analysis1.  Introduction
Multidimensional liquid chromatography (MDLC) improves
the separation of highly complex mixtures, and has been
applied to proteomics, lipidomics and the analysis of nat-
ural compounds [1]. In both qualitative and quantitative
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of quantitative analysis [2,3]. Generally, compared to age; FDR, false discovery rate; GO, gene ontology; HILIC, hydrophilic
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1D-chromatography, combining multiple chromatographic
separations will enhance resolving power, limit of detection
and dynamic range by signiﬁcantly increasing peak capacity
 European Proteomics Association (EuPA). This is an open access
enses/by-nc-nd/4.0/).
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4]. Common LC techniques used in MDLC include high-
H and low-pH RP, anion or cation exchange, size-exclusion
hromatography as well as hydrophilic interaction chromatog-
aphy (HILIC) and afﬁnity chromatography [5]. Orthogonality
f separation is an important parameter for achieving a high
eak capacity, thus most common examples include high-low
H RP-RP, strong cation exchange (SCX)-RP and HILIC-RP for
xpanding proteome coverage [6].
Ion-exchange chromatography is often used as a ﬁrst
imension of separation. In principle, there are two  modes
f ion exchange separation: cation and anion exchange. Com-
ining SCX with RP chromatography offers high orthogonality,
s SCX has a high loading capacity while RP can achieve high
esolution separations amenable to LC–MS analysis and both
nvolve different mechanisms [7]. It is also possible to com-
ine two complementary ion (cation and anion) exchange
olumns either in tandem or as part of a mixed-bed column
or increased separation efﬁciency. Havugimana et al. high-
ighted, in 2007, an improved number of identiﬁed proteins
nd higher quality of proteomics data using a “dual-column”
pproach with weak anion exchange (WAX) column coupled
o a moderate cation exchange (MCX) column for the anal-
sis of mouse heart cytosol [8]. Motoyama  et al. published,
n the same year, a study with increased number of identi-
ed proteins in yeast using a mixed-bed weak cation/weak
nion exchange (CATWAX) column [9]. The use of a 3D-LC–MS
pproach incorporating CATWAX and SCX for protein and pep-
ide fractionation was also reported by Zhang et al. to facilitate
n-depth protein identiﬁcation in mouse mammary  tumor 4T1
ell lysate [10].
Liver plays a crucial role in the metabolism of xenobi-
tics through numerous enzymes involved in detoxiﬁcation.
 signiﬁcant portion of these enzymes can be enriched in the
icrosomal fraction during subcellular fractionation [11] and
herefore liver microsomes are often used in drug metabolism
tudies. Microsomes are rich sources of membrane proteins
rom endoplasmic reticulum, plasma membrane, mitochon-
ria, and Golgi apparatus [12]. Integral membrane proteins
IMPs) represent the most pharmaceutically useful class of
eceptors [13], the targets of 70–80% of all known drugs
12], having strong implications in cell survival [14]. How-
ver, they are often tightly bound or physically integrated
nto the membrane and thus pose technical difﬁculties for
roteomic analysis [15]. Liver S9 fraction, a mixture of micro-
omal and cytosolic fractions, is another important sample
o study as it and is also often employed in toxicologi-
al and drug metabolism studies [16]. Since an important
oal in proteomics research aims at determining post-
ranslational modiﬁcations (including covalent binding from
eactive endogenous/exogenous species) [17], an ideal method
ould achieve very high sequence coverage of all potentially
argeted proteins.
We  previously reported [18] an approach for the proteomic
nalysis of rat liver microsomes examining different com-
inations of proteases and solubilizing agents using single
igestion, serial dual digestion and parallel dual digestion
orkﬂows. An SDS-assisted parallel tryptic–peptic dual diges-
ion method exhibited the highest proteome coverage with 768
roteins identiﬁed at 1% global false discovery rate (25% aver-
ge protein sequence coverage) with a high proportion (19.3%) 6 ( 2 0 1 5 ) 16–27 17
of integral membrane proteins. To further enhance proteome
coverage, the present study compares several MDLC-based
separations of rat liver microsomal and S9 fractions incorpo-
rating both protein-level and peptide-level fractionation. Four
strategies were devised to optimize the proteomic analysis of
rat liver samples combining ion exchange with reverse-phase
chromatography coupled to high-resolution quadrupole-time-
of-ﬂight (QqTOF) mass spectrometry. The approach with the
best overall performance was then selected to carry out
a cross-species proteomics comparison of rat, mouse and
human liver fractions.
The main goal of this work was to improve the proteome
coverage for samples of speciﬁc interest to drug metabolism
and toxicology research, relatively rich in membrane pro-
teins, where achieving high sequence coverage is particularly
challenging. The increased coverage of individual proteins
enhances the conﬁdence of their detection with a higher
number of peptides per protein, therefore yielding a better
potential for accurate protein quantitation. For instance, this
study is particularly useful for applications involving the abso-
lute quantitation and expression proﬁling of cytochrome P450
and UDP-glucuronosyltransferase enzymes [19–21]. Moreover,
when speciﬁc protein modiﬁcations are studied, higher pro-
tein coverage would increase the chances of seeing such
modiﬁcations in complex samples.
2.  Materials  and  methods
2.1.  Materials
Male Sprague-Dawley rat, male ICR/CD-1 mouse, and human
(M-50 donor) pooled liver microsomes (20 mg/ml  protein) were
purchased from Celsis In Vitro Technologies (Baltimore, MD).
Rat liver S9 fractions (37.5 mg/ml  protein) were from Moltox
(Boone, NC), while male CD-1 mouse and human liver S9 frac-
tions (20 mg/ml  protein) were purchased from BD Biosciences
(Franklin Lakes, NJ). Sequencing-grade modiﬁed trypsin was
obtained from Promega (Madison, WI). Porcine gastric mucosa
pepsin and all other chemical reagents were purchased from
Sigma–Aldrich (St. Louis, MO). HPLC-grade ACN, methanol and
isopropanol were from Caledon (Georgetown, ON), and ultra-
pure water was from a Millipore Synergy UV system (Billerica,
MA).
2.2.  Sample  digestion
Liver microsomes or S9 fractions (0.5–0.6 mg  protein) were
solubilized with a 2% SDS solution (1:1, v/v), heated at 95 ◦C
for 3 min, and diluted with 0.1 M ammonium bicarbonate
(pH 8.5) to 200 l. Reductive alkylation was performed using
DTT (2.5 mM,  10 min, 25 ◦C) and iodoacetamide (5 mM,  30 min,
37 ◦C, dark). Samples were diluted with 150 l of 0.1 M ammo-
nium bicarbonate (pH 8.5) for trypsin digestions or 0.2% TFA
in 20% methanol for pepsin digestions, and incubated at a
1:50 (w/w) enzyme:protein ratio for 18 h, at 37 ◦C for trypsin
and 25 ◦C for pepsin with an additional 15 l of 10% TFA prior
to adding pepsin samples to maintain the required acidic
digestion conditions (pH 1.5–2). CATWAX protein fractions
were reconstituted in 150 l of 0.1 M ammonium bicarbonate
o m i c18  e u  p a o p e n p r o t e 
(pH 8.5), denatured and digested using 5 g of either enzyme.
Digestion was quenched by adding 50 l of 1% formic acid for
trypsin or 1% ammonium hydroxide for pepsin. Samples were
then diluted with 500 l H2O prior to solid-phase extraction
(SPE) on a 1 cc (30 mg)  OASIS HLB cartridge (Waters, Milford,
MA), eluting with 100% methanol (1 ml). Resulting samples
were evaporated to dryness under vacuum (Thermo Fisher Sci-
entiﬁc Universal Vacuum System, Asheville, NC) and stored at
−30 ◦C.
2.3.  Protein  fractionation
Solubilized protein samples (1.4 mg total) were diluted with
buffer A (see below) to have a total volume of 280 l (5 mg/ml),
sonicated (1 min) and then ﬁltered using a Costar Spin-X
0.45 m cellulose acetate centrifuge tube ﬁlter (Corning, Corn-
ing, NY) prior to injection (100 l, 0.5 mg  protein) onto a
PolyCATWAX 200 mm × 2.1 mm column with 5 m (1000 A˚)
particles (PolyLC, Columbia, MD)  using an Agilent 1200 series
HPLC (Agilent Technologies, Palo Alto, CA) equipped with
a binary pump, degasser, diode array detector and frac-
tion collector. Mixed-bed weak cation/weak anion exchange
(WCX/WAX or CATWAX) fractionation was performed at a ﬂow
rate of 200 l/min using a gradient of 100% A held for 1 min,
up to 8% B at 8 min, 85% B at 9.5 min, then 100% B at 12.5 min,
and held at 100% B for an additional 17.5 min, where buffers
A and B were 10 mM and 800 mM ammonium acetate in 20%
acetonitrile (pH 7.2), respectively. The stand-alone weak cation
exchange (WCX) and weak anion exchange (WAX) separations
were performed on PolyCAT and PolyWAX 100 mm × 2.1 mm
columns with 5 m (1000 A˚) particles (PolyLC, Columbia, MD),
respectively. The WCX  and WAX columns were also used
in serial WCX-WAX and WAX-WCX conﬁgurations for dual-
column weak cation/weak anion exchange experiments. In all
cases, the UV absorbance was monitored at 220 and 280 nm.
From the CATWAX separation, six fractions were collected
over 22 min. The fractions were collected at the following
intervals: 0–2, 2–4, 4–6, 6–14, 14–18 and 18–22 min, which were
then evaporated to dryness under vacuum and kept at −30 ◦C
prior to digestion.
2.4.  Peptide  fractionation
Protein digests were reconstituted in buffer A (120 l, see
below), sonicated (10 min), and centrifuged (5 min, 14,000 × g)
prior to injection (100 l, 0.5 mg  protein) onto a Zorbax 300-SCX
150 mm × 2.1 mm column with 5 m (300 A˚) particles (Agilent
Technologies, Palo Alto, CA) using the same HPLC system as
for protein fractionation. SCX fractionation was performed at a
ﬂow rate of 250 l/min with a gradient of 0–50% B in 15 min, up
to 100% B at 25 min, then held for an additional 5 min  at 100%
B, where buffers A and B were 10 mM potassium dihydrogen
phosphate in 25% acetonitrile (pH 2.75), and 1 M potassium
chloride in buffer A (pH 2.75), respectively. UV absorbance
was monitored at 220 and 280 nm.  For trypsin samples, 3 min
(0.75 ml)  fractions were aliquoted into 1.5 ml  tubes between
1.5 and 19.5 min, while for pepsin, 4 min  (1.0 ml)  fractions were
collected between 1.5 and 25.5 min. Fractions were evaporated
to dryness under vacuum and kept at −30 ◦C. s 6 ( 2 0 1 5 ) 16–27
2.5.  RP-UHPLC–MS/MS  analysis
Dried samples were reconstituted in 10% acetonitrile
(100 l) and injected (20 l) onto an Aeris PEPTIDE XB-C18
100 mm × 2.1 mm column, with solid core 1.7 m particles
(100 A˚) (Phenomenex, Torrance, CA) on a Nexera UHPLC sys-
tem (Shimadzu, Columbia, MD) with water (A) and acetonitrile
(B), both containing 0.1% formic acid, at a ﬂow rate of
300 l/min (40 ◦C). The gradient started at 5% B, held for 2 min,
and was increased linearly to 30% B at 24 min, to 50% B at
26 min, then to 85% B at 26.5 min. MS and MS/MS  spectra
were collected on a high-resolution TripleTOF 5600 mass spec-
trometer (AB Sciex, Concord, ON) equipped with a DuoSpray
ion source in positive ion mode. The instrument performed a
survey TOF-MS acquisition from m/z 140 to 1250 (250 ms accu-
mulation time), followed by MS/MS  on the 15 most intense
precursor ions from m/z 250 to 1250 (excluded for 20 s after two
occurrences) using information-dependent acquisition (IDA)
with dynamic background subtraction. Each MS/MS acquisi-
tion had an accumulation time of 50 ms  and collision energy
of 30 ± 10 V. The total cycle time was 1.05 s.
2.6.  Data  treatment
MS/MS ﬁles from each workﬂow were combined and searched
against the UniProt protein database (release date 26/06/2013)
by ProteinPilot software (version 4.1) for the speciﬁed species
(rat, mouse, or human) using Paragon algorithm [22], includ-
ing false discovery rate (FDR) analysis and detection protein
threshold of unused ProtScore > 0.05 (conﬁdence > 10%). The
search was performed for +2 to +4 charge states and MS  toler-
ance was 0.05 Da on precursor ions and 0.1 Da on fragments.
All duplicates were ﬁrst processed alone, then together and
ﬁnally tryptic and peptic digest for each sample were co-
processed together. All strategies were then combined into a
“master” ﬁle to represent the total number of proteins and
peptides identiﬁed from all methods. Proteins were identiﬁed
with a 1% global false discovery rate (FDR) using a target-decoy
database search algorithm [23].
The list of UniProt accession numbers from identiﬁed pro-
teins was uploaded to NCBI Batch Entrez to obtain the batch
FASTA ﬁle, which was subsequently submitted to ExPASy for
determination of isoelectric point and monoisotopic molecu-
lar weight and to Phobius [24] for prediction of IMPs, based on
having at least one transmembrane domain (TMD ≥ 1). GRAVY
Calculator was used to calculate grand average of hydropa-
thy (GRAVY) scores. The list of accession numbers was also
uploaded to PANTHER [25] for gene ontology (GO) classiﬁca-
tion. Venn diagrams were created by Venny interactive Venn
diagram plotter (BioinfoGP) [26] while Clustal Omega [27] was
used for multiple sequence alignment (MSA) analysis of the
proteins unique to each dataset.
3.  Results  and  discussionsDifferent sample fractionation methods were compared to
achieve high proteome coverage for the analysis of rat
liver microsomal (RLM) and S9 fractions (RLS). Several com-
binations of separation techniques including solid-phase
e u  p a o p e n p r o t e o m i c s 6 ( 2 0 1 5 ) 16–27 19
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Fig. 1 – MDLC–MS/MS proteomic analysis workﬂow.
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WCX. Tandem combinations of WCX-WAX and WAX-WCXxtraction (SPE), peptide-level ion exchange fractionation,
nd protein-level ion exchange fractionation were evaluated
Fig. 1). Each workﬂow was performed on pepsin and trypsin
igested samples. The method with the best performance was
hen applied to the analysis of rat, mouse and human liver
icrosomal and S9 fractions. This cross-species comparison
nveiled large overlaps between the datasets obtained and fur-
her analysis of the results shed light on possible orthologs
etween the species.
.1.  Method  optimization
or protein solubilization, SDS is often used, however, it is
nown to cause technical difﬁculties, interfering with down-
tream MS  analysis, thus needs to be effectively removed prior
o LC–MS [28]. In previous work, SDS-assisted tryptic digestion
ielded better results than several other solubilizing agents
hen peptide-level ion exchange fractionation was performed
rior to LC–MS analysis [18]. The current study also tested the
ffect of SDS on pepsin digestion efﬁciency with and without
etergent removal by TCA precipitation. The SDS-solubilized
eptic digestion without TCA precipitation yielded the highest
umber of identiﬁed proteins at a 1% ﬁnal SDS concentration
in 0.1% TFA, 10% methanol) (data not shown). During the SPE
lean-up step, different elution conditions were tested on pep-
ic digests (from RLM and RLS) using OASIS HLB cartridges
Waters, Milford, MA). Elution with 100% methanol yielded the
ighest number of identiﬁed peptides and proteins at 1% FDR,
ollowed by a 60:40 mixture of ACN/isopropanol, and 100%
CN exhibited the least favorable results (unpublished data).
For LC–MS/MS acquisition, elution gradients and MS/MS
arameters were assessed for the analysis of RLM digests
after SPE clean-up). The LC method employed in previous
ork [18] was further optimized by varying ﬂow rates and
radient conditions slightly, with the goal of keeping a reason-
ble throughput (30–40 min  per run). A ﬂow rate of 300 l/min
ffered better separation efﬁciency compared to 250 and
50 l/min using the solid-core 1.7 m C18 column. Based onthe total ion chromatogram (TIC) of the TOF-MS survey scan;
the gradient was modiﬁed to 5% B held for 2 min, gradually
increased to 30% B at 24 min, to 50% B at 26 min, then to 85%
B at 26.5 min  and held for 2 min. These LC conditions yielded
extremely reproducible retention times between samples over
the course of this study. In terms of IDA criteria, the maximum
number of candidate ions for the MS/MS dependent scans per
cycle was varied between 5 and 20 ions with an accumulation
time ranging from 50 to 200 ms  for each MS/MS.  The intensity
threshold of the IDA candidate ions was also varied from 200 to
500 cps and isotope exclusion was tested at 2 or 3 Da. Moreover,
MS/MS  acquisition of the precursor ion was excluded after
two MS/MS scans for either 15, 20 or 30 s. Optimization of the
IDA-MS/MS parameters resulted in 15 MS/MS with 50 ms  accu-
mulation time each, a 3 Da isotope exclusion and 20 s dynamic
exclusion for selected precursor ions. This led to a signiﬁcant
improvement of the number of identiﬁed peptides, proteins
and IMPs as well as higher average protein sequence % cov-
erage and shorter total cycle time (summarized in Table 1).
A more  detailed comparison can be found in Supplemental
Table S1.
3.2.  2D-LC–MS/MS  using  protein-level  fractionation
For protein pre-fractionation of microsomal and S9 fractions,
ﬁve workﬂows were examined in this study, incorporating
WCX  and WAX in different combinations. Single WCX  and
WAX runs were compared to tandem WCX-WAX and WAX-
WCX  using two columns in series, as well as mixed-bed
WCX/WAX (CATWAX) using identical gradient conditions.
Judging by the LC–UV traces, single ion-exchange did not yield
satisfactory separations, though WAX did perform better thanimproved the separation, although CATWAX provided more
resolution due to the potential of retaining both negatively
and positively charged proteins over the single column in a
homogeneous manner (Supplemental Figure S1).
20  e u  p a o p e n p r o t e o m i c s 6 ( 2 0 1 5 ) 16–27
Table 1 – Improvements achieved by optimization of the IDA–MS/MS parameters.
Initial conditionsa Optimized conditionsb 
# Peptides (1% FDR) 7570 17,566 132%
# Proteins (1% FDR) 768 1120 46%
Avg. seq. % coverage 25.0 29.9 20%
# IMP 147  217 48%
Acquisition speed 1.30 s/cycle 1.05 s/cycle −19%
a 10 MS/MS scans (100 ms accumulation time) without dynamic exclusion.
sionb 15 MS/MS scans (50 ms accumulation time) with 20 s dynamic exclu
3.3.  2D-LC–MS/MS  using  peptide-level  fractionation
LC–UV traces from SCX fractionation of the microsomal and S9
digested samples demonstrated a separation pattern similar
to that of the protein-level fractionation (two elution zones).
Tryptic digests gave a more  signiﬁcant UV absorption in the
second portion than the earlier elution zone at 2–5 min, com-
pared to pepsin, which seemed to have a wider elution proﬁle
overall. This is attributed to the tendency of trypsin to cleave
after lysine and arginine residues resulting in more  basic pep-
tides strongly binding to the aromatic sulfonic acid groups of
the SCX column. The wider spread of elution for peptic digests
was attributed to more  variety possible in terms of basic-
ity as pepsin cuts at non-charged (hydrophobic) amino acids
(Fig. 2).
Previous work using 2D(SCX-RP)-LC–MS/MS for rat liver
microsomes [18] incorporated a protein precipitation step
prior to digestion to remove membrane-associated impuri-
ties as well as excess reagents which may hinder digestion
or affect SCX separation efﬁciency [29]. This precipitation step
was replaced by a SPE clean-up step prior to SCX fractionation,
to achieve good separation efﬁciency.
3.4.  3D-LC–MS/MS  (combined  protein-  and
peptide-level  fractionation)
LC–MS/MS analysis with multiple dimensions of pre-
fractionation has proven useful in proteomics research
[2], with reports of improved protein/peptide identiﬁcation
[30–32], higher peptide selectivity [33] and more  efﬁcient
detection of modiﬁcations [34,35]. However, most of these
have combined successive LC steps at the peptide level.
In this study, the 3D-LC–MS/MS approach tested combined
protein-level (CATWAX) with dual peptide-level (SCX-RP)
separations. Unfortunately, the results showed poor perfor-
mance compared to both regular 1D-(RP) and the 2D-(SCX-RP)
methods. All protein-level fractions, when subjected to pep-
tide fractionation, yielded identical chromatographic traces.
Several sample treatment workﬂows were tested incorpo-
rating SDS-assisted solubilization or acetone/TCA protein
precipitation, however, no signiﬁcant improvement was
observed.
3.5.  Tryptic  versus  peptic  digestionA parallel tryptic–peptic dual digestion was performed for the
analysis of rat liver microsomes for increased proteome cover-
age due to the complementary cleavage sites between the two.
enzymes [18]. Trypsin normally cleaves at basic amino acid
residues such as arginine and lysine which are more  abun-
dant in water-soluble proteins. Pepsin, on the other hand,
targets residues with hydrophobic and preferably aromatic
side chains such as leucine, phenylalanine, tryptophan, and
tyrosine [36], likely found in less water-soluble regions, such
as membrane proteins. Microsomes (and S9 fractions) are
rich sources of membrane proteins and therefore a combined
tryptic–peptic digestion enhances the proteome coverage
as pepsin cleaves regions embedded inside (or associated
with) the membrane while trypsin cuts more  solvent-exposed
regions. Table 2 summarizes the results obtained from trypsin
and pepsin digestions using four fractionation strategies. As
expected, trypsin led to a higher number of identiﬁed proteins
and peptides, while pepsin often yielded an increased %IMP.
Moreover, replicate analysis showed that, overall, trypsin sam-
ples had better reproducibility compared to pepsin samples
(see Supplemental Table S2). It was also observed that 23–51%
of the identiﬁed proteins were shared between trypsin and
pepsin, 37–72% were unique to trypsin, and 4–12% were unique
to peptic digestion. The pepsin-unique proteins included more
IMPs (up to 40%) compared to trypsin-speciﬁc proteins (up to
20%). More details on the overlap analysis can be found in
Supplemental Table S3.
3.6.  Comparison  of  the  four  workﬂows
The results from 1D-, 2D- and 3D-LC–MS/MS approaches
showed signiﬁcantly superior performance of the 2D-(SCX-RP)
workﬂow. Based on previous research [9,10], it was expected
that the best performance would be seen with the 3D strategy,
combining fractionation at both protein and peptide levels.
Nevertheless, the 2D-(CATWAX-RP) and 3D-(CATWAX-SCX-RP)
methods led to less satisfactory results even compared to the
regular 1D-RP (Table 2). This is most likely related to sam-
ple loss related to protein fractionation. Proteins identiﬁed
exclusively with sample preparation workﬂows involving pro-
tein fractionation were compared between RLM (94 proteins)
and RLS (86 proteins). What was seen is that most (90%) of
these 154 proteins (RLM + RLS, non-redundant) have negative
GRAVY scores; hence they are more  water soluble. This is in
line with the assumption that recovery problems from pro-
tein fractionation workﬂows were caused by solubility issues.
Separating complex mixtures of proteins is challenging, espe-
cially for samples containing membrane proteins such as liver
microsomes/S9 fractions.
Using the 2D-SCX-RP method (combining trypsin + pepsin
digestion results), 17,566 distinct peptides were detected
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1% FDR) in RLM leading to 1120 identiﬁed proteins (1% FDR),
ith ∼30% average protein sequence coverage, out of which
12 proteins (19%) were predicted to be transmembrane pro-
eins (based on analysis using Phobius). From RLS samples,
5,905 distinct peptides and 1037 proteins were found with
8% protein sequence coverage. The S9 fractions also con-
ained less transmembrane proteins (102, equivalent to 10%),
hich was anticipated, since both cytosolic and microsomal
roteins are present [37]. Both sample types yielded the same
anking of performance between 1D, 2D-CATWAX-RP and 3D
orkﬂows (Table 2). The 2D-SCX-RP approach provided the
ighest number of unique proteins (486 in RLM, 440 in RLS).
Table 2 – Comparative results from the analysis of rat liver micr
fractionation approaches (trypsin, pepsin, and the two enzyme
Samplea Approach Digestion Proteinsb Pe
RLM
1D
Trypsin  543 
Pepsin 390 
Combined 586 
CATWAX
Trypsin 286 
Pepsin 138 
Combined 297 
SCX
Trypsin 1089 1
Pepsin 610 
Combined 1120 1
3D
Trypsin 365 
Pepsin 177 
Combined 370 
RLS
1D
Trypsin 521 
Pepsin 320 
Combined 569 
CATWAX
Trypsin 253 
Pepsin 74 
Combined 260 
SCX
Trypsin 1015 1
Pepsin 502 
Combined 1037 1
3D
Trypsin 175 
Pepsin 67 
Combined 174 
a Data combined from duplicate samples.
b Total number of proteins/peptides identiﬁed (from duplicate samples) w
c Percentage of integral membrane proteins identiﬁed for each condition.A total number of 170 in RLM and 96 in RLS were common to
all four workﬂows (Fig. 3). Moreover, if average sequence cover-
age is compared for these shared proteins, the SCX-RP method
was again superior (61% vs 43% for 1D, 22% for CATWAX-RP,
and 23% for 3D).
3.7.  Rat  proteome  results
The rat liver proteome has been widely studied with the aim
of improving existing knowledge on this specialized tissue.
Several recent studies were performed to address questions
in pathogenesis and development of liver cancer and chronic
osomes (RLM) and S9 fractions (RLS) using the four
s combined).
ptidesb Avg. sequence coverage (%) IMP  (%IMP)c
4643 22.2 96 (17.7)
2453 16.0 90 (23.1)
7049 27.1 107 (18.3)
1384 16.1 23 (8.0)
848 20.6 7 (5.1)
2188 19.8 20 (6.7)
2,111 24.8 217 (19.9)
5251 20.9 134 (22.0)
7,566 29.9 212 (18.9)
1493 15.0 39 (10.7)
737 13.5 20 (11.3)
2109 16.8 45 (12.2)
4721 22.1 51 (9.8)
1817 13.4 33 (10.3)
6497 24.0 52 (9.1)
1190 17.8 13 (5.1)
541 24.1 2 (2.7)
1707 20.1 10 (3.8)
1,453 25.0 101 (10.0)
4291 18.4 51 (10.2)
5,905 28.4 102 (9.8)
676 14.4 15 (8.0)
325 17.5 4 (6.0)
975 15.8 14 (8.0)
ith 1% FDR.
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Fig. 3 – Venn diagrams representing the number of identiﬁed proteins in RLM (left) and RLS (right) using 1D-, 2D-  and
3D-LC–MS/MS workﬂows.
diseases [38–40], drug evaluation [41] and drug-induced liver
injury [42–45], and understanding of cellular functions [46–48].
Most recently, in an extensive study on whole rat liver
homogenate, using an integrated “omics” approach on two
rat strains (BN-Lx and SHR) combining multiple proteases
(trypsin, Lys-C, Glu-C, Asp-N, and chymotrypsin), SCX frac-
tionation and LC-MS/MS analysis on two platforms (TripleTOF
5600 and LTQ-Orbitrap Velos), Low et al. obtained peptide evi-
dence for 26,463 proteins with an overall sequence coverage
of 15.6% [38]. This impressive result was obtained based on
searching a custom-built database with the goal of achiev-
ing a complete inventory of genetic variation, combining data
from genome and RNA sequencing, which includes genetic
polymorphisms and post-transcriptional events. For compar-
ative purposes, the analysis presented here was performed
on Sprague-Dawley rat liver fractions with two proteases
and one MS/MS  platform, using the UniProt KB/Swiss-
Prot database, comprising total of 7887 reviewed protein
entries.
The current study incorporated a total of 491,615 (RLM)
and 426,812 (RLS) high-resolution MS/MS  spectra from the
four strategies leading to the identiﬁcation of 1185 (RLM) and
1081 (RLS) proteins at 1% FDR, of which 796 proteins (54%)
were common between the two datasets, while 674 proteins
(46%) were unique to either microsomes or S9 fraction.
Combining the two  datasets and removing redundancies, a
total number of 1400 proteins were identiﬁed in the studied
rat liver fractions, of which 1235 (88.2%) were also reported by
Low et al. [38].
Using Phobius (combined transmembrane topology and
signal peptide predictor) [24], 215 and 103 IMPs was found
in RLM (18% identiﬁed proteins) and RLS (10% identiﬁed
proteins), respectively. An average of 5 and 7 peptides (con-
ﬁdence >95%) were detected for each protein in RLM and RLS,
respectively. However, the average protein sequence coverage
was similar between RLM (31.4%) and RLS (29.9%) samples.
Sequence coverage is of particular importance for studies
involving protein modiﬁcations, since the higher the coverage,
the better the chances of detecting covalent modiﬁcations on a
target protein. Our group is particularly interested in elucidat-
ing novel protein targets of reactive molecules and therefore
this was set as a high priority when optimizing the proteomic
analysis workﬂow.Characterizing the overall distribution of pI, molecular
weights, and GRAVY scores is of interest when optimizing
sample preparation steps (ion exchange, SPE, etc.) for increas-
ing coverage of the proteomic analysis. Therefore, an in-depth
analysis of the identiﬁed proteins was performed on the
rat liver samples. From the compiled dataset, RLM and RLS
proteins were analyzed in terms of their physicochemical
properties. A comparison of protein pI revealed that the major-
ity of rat liver proteins have a theoretical pI in the range
of 4–12 with 43.4% (RLM) and 34.8% (RLS) with basic char-
acteristics (pI  > 7). Considering the MW distribution, 2–3% of
proteins were below 10 kDa, 60–62% in the range from 10 to
50 kDa, 29–30% in the range from 50 to 100 kDa, and 6–7% above
100 kDa, with an average molecular mass of 48.2 and 50.1 kDa
for RLM and RLS, respectively. The identiﬁed proteins were
also analyzed in terms of hydropathy (as measured by GRAVY
scores). With a GRAVY score distribution in the range from
−2.0 to 1.1, 16.8% of RLM and 12.9% of RLS proteins were char-
acterized as hydrophobic (GRAVY < 0), coinciding well with the
%IMPs predicted by Phobius (Fig. 4). The identiﬁed proteins
in rat liver samples were also analyzed in terms of biologi-
cal properties using PANTHER [25]. As depicted in Fig. 5, GO
analysis classiﬁed RLM and RLS proteins into 10 groups based
on their molecular functions, over 45% of which represent
catalytic functions. Interestingly, there were more  transporter
and receptor proteins identiﬁed in the microsomes than in the
S9 fraction whereas the latter sample was richer in structural,
molecule-binding, translation and enzyme regulator proteins.
When classiﬁed by biological processes, 12 groups were iden-
tiﬁed with the highest proportion being involved in metabolic
and cellular processes. However, it was seen that a slightly
higher proportion of the microsomal proteins were involved
in localization and multicellular organismal processes, while
more  proteins were associated with biological regulation, cel-
lular, developmental and metabolic processes from the S9
fraction. Many of these proteins play a crucial role in the
metabolism of xenobiotics and thus are interesting for toxi-
cology and drug discovery studies.3.8.  Cross-species  comparison  of  liver  proteins
Rat and mouse are common animal models for various
applications related to human metabolism, pharmacology
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LM and RLS.AVY score (below) as a function of MW for the proteins
were compared. Table 3 summarizes the results from the
analysis of microsomal and S9 fractions of all three species.
Overall, 1400 distinct proteins were identiﬁed at 1% FDR in
rat, 1791 in mouse, and 1939 in human with an average
sequence coverage of 23–30%, an average of 8–10 peptides
(conﬁdence > 95%) per protein, and a reproducibility of 62–80%
(for separately fractionated duplicate samples). Also, similar to
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Table 3 – Proteomic analysis of rat, mouse and human liver microsomes and S9 fractions using the optimized
2D-LC–MS/MS method.
Species Sample Proteinsa Peptidesa IMP  (%) Sequence %
coverageb
Peptides per
proteinb
Total proteinsa
Rattus norvegicus
Microsomes 1120 17,566 217 (19.4) 29.9 10
1400
S9 fraction 1037 15,905 104 (10.0) 28.4 10
Mus musculus
Microsomes 1582 19,262 294 (18.6) 24.9 8
1791
S9 fraction 1538 18,089 271 (17.6) 22.9 8
Homo sapiens
Microsomes 1516 18,739 308 (20.3) 24.0 8
1939
S9 fraction 1570 20,435 188 (12.0) 24.2 8a Number of proteins and peptides at 1% FDR
b Average of all identiﬁed proteins
rat, microsomes contained a higher number of IMPs than S9
fractions in both mouse and human. As expected, the proteins
identiﬁed in the three species demonstrated a high amount
of similarity in terms of both physicochemical and biological
properties, as illustrated in Supplemental Figures S2-S3. As
for isoelectric points, 38.6–43.1% of the proteins have pI > 7,
whereas 15.6–16.4% could be classiﬁed as hydrophobic, coin-
ciding well with the number of IMPs in each sample. Moreover,
GO classiﬁcation revealed that rat, mouse and human liver
Fig. 6 – Venn diagrams depicting the number of shared and uniq
microsomal (left) and liver S9 (right) proteins.
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number”).proteins are analogous in terms of function and involvement
in biological processes, as expected.
As shown in Fig. 6, when a cross-species analysis was per-
formed, comparing gene IDs only, on all datasets, 31.3% and
28.0% orthologous proteins were found between the three
species for microsomal and S9 fractions, respectively, while
approximately 44% were deemed as unique to one species.
The combined results from microsomal and S9 fractions are
shown in Supplemental Figure S4. MSA analysis, performed
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o assess the non-orthologous proteins, demonstrated that for
2.6% (microsomal) and 24.6% (S9) of these proteins had rea-
onable sequence similarities, with at least 10% inter-species
omology (Fig. 7). Taking into consideration all the identi-
ed proteins (microsomal and S9), MSA  analysis revealed that
he set of human proteins are slightly more  homologous to
at than mouse (Supplemental Figure S5). Percent identity
atrices (PIMs) and phylogenetic trees from this analysis are
vailable in Supplemental Table S4.
A complete list of the proteins identiﬁed (at 1% FDR) in
ach sample, and the distinct peptides detected for each pro-
ein is published as a Data in Brief article [51]. In this related
rticle, links to publicly accessible repositories are provided.
n an effort to quantify the impact of making this data pub-
icly available, the lists of peptides from tryptic digestion of
uman, mouse and rat samples were compared to the most
ecent database entries on PeptideAtlas (2013-11, 2014-12 and
014-08 builds for rat, mouse and human, respectively) [52].
emarkably, a relatively large proportion of our highly conﬁ-
ent peptides were not found in the most current version of
eptideAtlas (20.1% of the human peptides, and 35.8% for each
f the mouse and rat peptide lists). Therefore, once incorpo-
ated, this large dataset would add a signiﬁcant amount of
dditional information into this publicly accessible database.
hese data would be useful for subsequent studies involv-
ng quantitative proteomics applications as well as further
robing of biological information contained in these rich
atasets.
Liver microsomes and S9 fractions are routinely used in
rug metabolism studies and therefore, an in-depth charac-
erization of the proteins contained in these fractions is of
articular interest for probing protein modiﬁcations resulting
ia drug bioactivation (reactive metabolites). Several studies
ave been performed with the goal of identifying protein tar-
ets of reactive compounds in liver microsomes [53–56], and
e anticipate this comprehensive proteomic analysis of these
hree species will facilitate future work in this challenging
rea.
.  Conclusion
ample preparation and enrichment is a crucial step in the
nalysis of complex samples and directly affects the efﬁ-
iency of any proteomic workﬂow. In this study, a parallel dual
igestion method followed by a comparison of different frac-
ionation strategies prior to UHPLC–MS/MS was employed in
he analysis of rat liver microsomal and S9 fractions.
Protein-level fractionation using mixed-bed weak
ation/anion exchange (CATWAX) did not improve pro-
eome coverage for these samples, compared to the
D(RP)-LC–MS/MS workﬂow and did not ameliorate results
hen combined with peptide-level SCX fractionation either.
he 2D(SCX-RP)-LC–MS/MS approach yielded the best results
nd was therefore chosen for the comparative analysis of rat,
ouse and human liver fractions.
Informative results including physicochemical properties
nd GO classiﬁcation of the identiﬁed proteins, as well as an
verall comparison of homology between the three species
as performed. 6 ( 2 0 1 5 ) 16–27 25
This study resulted in large sets of high-resolution MS/MS
data yielding impressive proteome coverage for challenging
liver fractions containing a relatively high number of mem-
brane proteins. The results of this work are of particular
interest to the drug discovery and toxicology communities.
This information could be speciﬁcally useful in several appli-
cations, for example cross-species extrapolation of toxicity,
characterizing protein modiﬁcations, and developing targeted
quantitative assays for veriﬁcation of potential biomarker
panels.
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